TNFSF10 and neoplasm: However, it was found that systemically administered TRAIL was trapped by normal cells overexpressing decoy receptors, which resulted in the low tumor uptake and subsequent inefficacy of TRAIL (LeBlanc & Ashkenazi, 2003; Merino et al., 2006).